Kj. Till et al., GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR-RECEPTOR - STAGE-SPECIFIC EXPRESSION AND FUNCTION ON LATE B-CELLS, Blood, 88(2), 1996, pp. 479-486
Granulocyte-macrophage colony-stimulating factor (GM-CSF) receptors (G
MR) are expressed on myeloid cells throughout their maturational seque
nce, During myelopoiesis, GM-CSF induces the proliferation of precurso
rs and has multiple effects on more mature cells; such effects include
induction of maturation and priming for subsequent stimulation. GMR i
s expressed on a range of other cell types including acute leukemic bl
asts of myeloid and lymphoid lineage, but has been little studied on m
ore mature lymphoid cells. Using sensitive triple-layer immunophenotyp
ic techniques, we show here that both the alpha and beta(c) chains of
the GMR are expressed on hairy cells (HCs) and myelomatous plasma cell
s (PCs), but not on chronic lymphocytic leukemia (CLL) or prolymphocyt
ic leukemia (PLL) lymphocytes. The receptor was demonstrable on normal
PCs in tonsil, but not on either activated or resting tonsillar B cel
ls or on circulating normal B lymphocytes. The expression of the recep
tor is therefore stage specific, rather than a feature of activation.
Perhaps, surprisingly, in view of its effects on myeloid cells, GM-CSF
did not stimulate the proliferation or differentiation of HCs and did
not protect them from apoptosis. However, the cytokine had a profound
effect on the interaction of the HC with its environment. Thus, the c
ytokine caused a major cytoskeletal reorganization resulting in the in
hibition of motility and loss of adhesion to cellular and matrix ligan
ds, These studies indicate the importance of GM-CSF outside myelopoies
is and demonstrate a previously unrecognized stage specific role for t
he cytokine in B-cell biology. Taken together with our previous report
that M-CSF enhances B-cell motility, the present findings indicate th
at myeloid growth factors act in concert to facilitate the controlled
migration of certain B cells into and within tissues. (C) 1996 by The
American Society of Hematology.